Newly Approved T1D Therapy Lantidra Could Eliminate Need for Insulin Injections
XTalks
JULY 3, 2023
The treatment is derived from deceased donor pancreatic cells and is indicated for patients who are unable to achieve average blood glucose levels (glycated hemoglobin) with daily insulin injections or with continuous infusion through a pump because of repeated episodes of severe hypoglycemia (low blood sugar).
Let's personalize your content